You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Docetaxel and Doxorubicin Codelivery by Nanocarriers for Synergistic Treatment of Prostate Cancer
|
|---|---|
| Published in |
Frontiers in Pharmacology, December 2019
|
| DOI | 10.3389/fphar.2019.01436 |
| Pubmed ID | |
| Authors |
Ke Li, Wenhua Zhan, Yulong Chen, Rajiv Kumar Jha, Xueli Chen |
X Demographics
The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Switzerland | 1 | 13% |
| India | 1 | 13% |
| Austria | 1 | 13% |
| Unknown | 5 | 63% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 50% |
| Practitioners (doctors, other healthcare professionals) | 2 | 25% |
| Science communicators (journalists, bloggers, editors) | 1 | 13% |
| Scientists | 1 | 13% |
Mendeley readers
The data shown below were compiled from readership statistics for 55 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 55 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 14 | 25% |
| Student > Ph. D. Student | 9 | 16% |
| Student > Bachelor | 4 | 7% |
| Professor | 2 | 4% |
| Researcher | 2 | 4% |
| Other | 7 | 13% |
| Unknown | 17 | 31% |
| Readers by discipline | Count | As % |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutical Science | 11 | 20% |
| Biochemistry, Genetics and Molecular Biology | 8 | 15% |
| Chemistry | 4 | 7% |
| Agricultural and Biological Sciences | 3 | 5% |
| Medicine and Dentistry | 3 | 5% |
| Other | 6 | 11% |
| Unknown | 20 | 36% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 February 2020.
All research outputs
#7,640,263
of 23,267,128 outputs
Outputs from Frontiers in Pharmacology
#3,424
of 16,699 outputs
Outputs of similar age
#164,727
of 458,883 outputs
Outputs of similar age from Frontiers in Pharmacology
#117
of 385 outputs
Altmetric has tracked 23,267,128 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 16,699 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 458,883 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.
We're also able to compare this research output to 385 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.